Memphasys Ltd
ASX:MEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Memphasys Ltd
ASX:MEM
|
AU |
|
N
|
Nordisk Bergteknik AB (publ)
STO:NORB B
|
SE |
|
Fleetpartners Group Ltd
ASX:FPR
|
AU |
|
BJ's Restaurants Inc
NASDAQ:BJRI
|
US |
|
Medtronic PLC
NYSE:MDT
|
IE |
|
Jensen-Group NV
XBRU:JEN
|
BE |
|
Aeries Technology Inc
NASDAQ:AERT
|
US |
|
B
|
Bergs Timber AB (publ)
STO:BRG B
|
SE |
|
Concejo AB (publ)
STO:CNCJO B
|
SE |
|
Eastone Century Technology Co Ltd
SZSE:300310
|
CN |
|
D
|
Dabaco Group
VN:DBC
|
VN |
|
Jiangsu Huaxin New Material Co Ltd
SZSE:300717
|
CN |
|
Perpetual Ltd
ASX:PPT
|
AU |
|
R
|
Rasan Information Technology Company SCJSC
SAU:8313
|
SA |
Memphasys Ltd
Memphasys Ltd. is a life sciences company. The company is headquartered in Homebush West, New South Wales. The company went IPO on 2007-05-14. The company develops medical devices, diagnostics and media with application to assists reproduction technologies in humans and animals. The Company’s lead product is Felix device. The Felix is an automated device for separating quality sperm from a semen sample for the use in human in vitro fertilization (IVF) procedures. The firm's membrane technology utilizes its separation technology along with its multiple devices and hydrogel membranes to fractionate biological molecules. The technology relies on the applied electric field and charged biological molecules. The sample and harvest chamber are formed by placing the separation membrane in between two restriction membranes with restricted pores.
Memphasys Ltd. is a life sciences company. The company is headquartered in Homebush West, New South Wales. The company went IPO on 2007-05-14. The company develops medical devices, diagnostics and media with application to assists reproduction technologies in humans and animals. The Company’s lead product is Felix device. The Felix is an automated device for separating quality sperm from a semen sample for the use in human in vitro fertilization (IVF) procedures. The firm's membrane technology utilizes its separation technology along with its multiple devices and hydrogel membranes to fractionate biological molecules. The technology relies on the applied electric field and charged biological molecules. The sample and harvest chamber are formed by placing the separation membrane in between two restriction membranes with restricted pores.